PT-141 (Bremelanotide) · Pastor Peptide

🔹 What is PT-141 (Bremelanotide)?

Class: Synthetic peptide; melanocortin receptor agonist (MC3R/MC4R). Originally derived from Melanotan II but modified to remove strong melanogenic activity. Mechanism:

Activates melanocortin receptors (MC3R, MC4R) in the hypothalamus.
Increases dopamine release, influencing arousal and sexual desire.
Distinct from PDE5 inhibitors (e.g., Viagra) → works on the brain and nervous system, not the vascular system.
Effects include heightened libido, improved erectile function, and enhanced sexual satisfaction in both men and women.

Primary focus:

Male erectile dysfunction (neurogenic or psychogenic).
Female sexual dysfunction (hypoactive sexual desire disorder).
Potential support in anhedonia and mood regulation (under exploration).

🔹 Oral Dosage

Not effective orally → PT-141 has poor oral bioavailability.
Some experimental sublingual or intranasal formats exist but are less predictable.

🔹 Injectable / Subcutaneous Dosage (most common) Range:

0.5–2 mg SC 30–60 minutes before sexual activity.
Starting dose: 0.5–1 mg to assess tolerance.
Higher doses (>2 mg) increase side effects (nausea, flushing, headache).

Frequency:

Used as needed, not daily.
Some follow a 1–2x/week schedule, depending on effect duration (can last 6–72 hours).

Rationale: Works centrally, so effects often last well beyond plasma clearance.

Real-world compounded example: PT-141 w/ B6, 10,000 mcg/ml vial (2 ml) — dosed at 0.1 ml SQ for males and 0.2 ml SQ for females, injected 30 minutes to 6 hours prior to sexual activity. The added vitamin B6 is a common compounding pharmacy practice paired with PT-141; it’s not considered a primary driver of the peptide’s effect.

🔹 Intranasal Dosage

PT-141 w/ B6, 5,000 mcg (10 ml nasal spray bottle) — dosed at 2–4 sprays per nostril, 30–60 minutes prior to sexual activity.
Offers a needle-free alternative to the SQ injection route, though absorption consistency may vary compared to injectable delivery.

🔹 Cycle Length

Generally episodic/as-needed use.
For ongoing dysfunction: 6–8 week cycles with breaks are sometimes used in research settings.

🔹 Optimal Dosing Window

30–60 minutes before activity.
Some report strongest effects at the 2–4 hour mark, lasting up to 1–3 days.
Evening use is common, though timing can vary by individual response.

✅ Educational Integration Example Example protocol: 1 mg SC injection, 45 minutes before sexual activity, max 2x per week. Paired with: L-Citrulline (3–6 g daily) to support vascular function. Rationale: Enhances central arousal pathways while supporting peripheral blood flow.

🔹 Stacking Strategy (Educational / Complementary) Since PT-141 primarily enhances libido and arousal via central pathways, stacks often target vascular support, mood regulation, and recovery: 🔸 Vascular & Performance Support

PDE5 inhibitors (Sildenafil, Tadalafil) → complement PT-141 by addressing penile blood flow while PT-141 drives desire.
L-Arginine or L-Citrulline → boost nitric oxide availability.

🔸 Mood & Neurotransmitter Balance

Selank or Semax → modulate anxiety and enhance dopamine/BDNF signaling.
Methylene Blue (low dose) → supports mitochondrial energy and mood.

🔸 Recovery & Longevity

GH secretagogues (CJC-1295/Ipamorelin, MK-677) → may support tissue repair, sleep, and long-term sexual health.
NAD⁺ / MOTS-c → sustain mitochondrial resilience during repeated use.

Rationale: PT-141 enhances central arousal, so stacking works best when pairing it with peripheral vasodilators, mood stabilizers, and metabolic support.

⚠️ Safety Notes

Common side effects: nausea, flushing, headache, increased blood pressure.
Contraindicated in uncontrolled hypertension or cardiovascular disease.
Overuse may desensitize melanocortin receptors or blunt natural arousal pathways.
FDA-approved as Vyleesi® for women with hypoactive sexual desire disorder (HSDD).

Studied in Humans? Yes

FDA Approved? Yes

Allowed for 503a Compounding Pharmacy? Yes, but limited.

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.